The British Menopause Society (BMS), established in 1989, educates, informs and guides Healthcare professionals on menopause and all aspects of post reproductive health. This is achieved through an annual programme of lectures, conferences, meetings, exhibitions and our interactive website. We offer a range of publications including our quarterly journal Post Reproductive Health and the definitive handbook Management of the Menopause.
Following the statement from the Prime Minister on 17 March 2020 and the current government recommendations, we have closed the office. It is, however, business as usual. The best way to contact us is via email.
– with Mr Haitham Hamoda
The full BMS Consensus Statement on Bioidentical HRT is available to non-Members for a limited time only.
Education programme overview
1 October 2020 - 2 October 2020
7 October 2020
28 October 2020 - 29 October 2020
12 November 2020 - 13 November 2020
13 November 2020 - 14 November 2020
17 November 2020 - 19 November 2020
19 November 2020 - 21 November 2020
19 November 2020 - 20 November 2020
1 December 2020
28 January 2021 - 29 January 2021
2 February 2021 - 3 February 2021
4 February 2021 - 7 February 2021
8 February 2021
- British Menopause Society further update on HRT supply shortages (28 September 2020)
- 28 September 2020
- The British Menopause Society has issued this further update on the current availability of HRT products to provide guidance to BMS members and clinical practitioners
- HRT and breast cancer statement in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020
- 14 September 2020
- This is an updated Joint BMS, IMS, EMAS, RCOG and AMS Position Statement on HRT and breast cancer risk and includes a summary of the
- BMS, IMS, EMAS, RCOG and AMS Joint Statement
- 18 August 2020
- A joint statement has been issued by the British Menopause Society, the International Menopause Society, the European Menopause and Andropause Society, the Royal College of Obstetricians and Gynaecologists and the Australasian Menopause Society on menopausal hormone therapy (MHT) and breast cancer risk in response to EMA Pharmacovigilance Risk Assessment Committee recommendations in May 2020.
- BMS, RCOG, RCGP, FSRH, FOM and FPH Position Statement
- 14 August 2020
- A joint statement has been issued by the British Menopause Society, the Royal College of Obstetricians and Gynaecologists, the Royal College of General Practitioners, the Faculty of Sexual and Reproductive Healthcare, the Faculty of Occupational Medicine and the Faculty of Public Health in response to the BMA report ‘Challenging the culture on menopause for doctors’.
- RCOG and BMS joint statement 29 July 2020
- 29 July 2020
- The RCOG and BMS issue a joint statement on the Women’s Health Initiative’s (WHI) study on HRT and breast cancer incidence and mortality.
BMS TV: The Menopause Explained
Our patient arm
Women’s Health Concern (WHC) was founded in 1979 and became the patient arm of the BMS in 2012. It provides an independent service to advise, reassure and educate women of all ages about their gynaecological and sexual health, wellbeing and lifestyle concerns.
Information for non-professionals can also be found at Menopause Matters.
The British Menopause Society is a specialist society associated with the Royal College of Obstetricians and Gynaecologists.
Conference and meeting reports
The 29th annual scientific conference, entitled “An integrated approach to menopausal care”, was held at Chesford Grange, Kenilworth on 4 & 5 July 2019.
Website last reviewed: